PCVX
Vaxcyte, Inc.
NASDAQ · Healthcare · Biotechnology · US
$61.25
+0.13%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 364.57x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.30x
- Price / sales
- —
- Price / cash flow
- -7.84x
Enterprise value
- Enterprise value
- $7.7B
- EV / sales
- —
- EV / EBITDA
- -7.36x
- EV / EBIT
- -6.64x
- Market cap
- $9.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026